← Leaderboards
John S. Cooperwood
Florida Agricultural And Mechanical Univ
$1,206,560
Attributed
$1,206,560
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $164.8K · FY2006–16$200K$150K$100K$50K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$1,206,560 · 7
By mechanism
P20$697,647 · 1
G12$508,913 · 6
Top collaborators
No co-investigators on record.
Most similar at Florida Agricultural And Mechanical Univ
Same institution · by research overlap
- Mandip Singh Sachdeva$9,672,283
Others in their field
Top investigators on “Breast Cancer Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$137,708,831
- Frank Patrick McCormick · University Of California San Francisco$90,363,768
- C Kent Osborne · Baylor College Of Medicine$64,905,231
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$61,526,584
- Monica M Bertagnolli · Strang Cancer Prevention Center$61,082,236
- William J. Blot · Vanderbilt University$60,929,890
Research focus
Breast Cancer CellGrowthMalignant Breast NeoplasmMalignant NeoplasmsDesignEstradiolEstrogen ReceptorsMolecular ModelsMolecular ModelingEstrogensLeadWomanMammary NeoplasmsChemotherapeutic AgentCytotoxicityStructureCollaborationsBaseHydroxyl GroupComputer StudiesCruciferous VegetableAnticancer ResearchCancer Cell LineCommunity Services
Grant awards (11)
Synthesis and Evaluation of DIM-like Analogues Targeting PI3K/Akt Pathway$155,651
P20 · FY2016 · MD · contact PI
Synthesis and Evaluation of DIM-like Analogues Targeting PI3K/Akt Pathway$158,435
P20 · FY2015 · MD · contact PI
Synthesis and Evaluation of DIM-like Analogues Targeting PI3K/Akt Pathway$145,024
P20 · FY2014 · MD · contact PI
Synthesis and Evaluation of DIM-like Analogues Targeting PI3K/Akt Pathway$73,692
P20 · FY2013 · MD · contact PI
Synthesis and Evaluation of DIM-like Analogues Targeting PI3K/Akt Pathway$164,845
P20 · FY2012 · MD · contact PI
SYNTHESIS & PHARMACOLOGICAL EVAL OF POTENTIAL ANTI-CANCER & ANTI MICROBIAL AGENT$93,636
G12 · FY2011 · RR · contact PI
SYNTHESIS & PHARMACOLOGICAL EVAL OF POTENTIAL ANTI-CANCER & ANTI MICROBIAL AGENT$110,744
G12 · FY2010 · RR · contact PI
SYNTHESIS & PHARMACOLOGICAL EVAL OF POTENTIAL ANTI-CANCER & ANTI MICROBIAL AGENT$117,288
G12 · FY2009 · RR · contact PI
DDR SUBPRJ 3: BREAST CANCER TARGETED ANTICANCER AGENTS$99,846
G12 · FY2008 · RR · contact PI
DDR SUBPRJ 3: BREAST CANCER TARGETED ANTICANCER AGENTS$44,335
G12 · FY2007 · RR · contact PI
DDR SUBPRJ 3: BREAST CANCER TARGETED ANTICANCER AGENTS$43,064
G12 · FY2006 · RR · contact PI